Skip to main content

Table 1 Demographic and clinical characteristics of military trainees according to etiology of febrile respiratory illness (2004-2009)

From: Retrospective analysis of demographic and clinical factors associated with etiology of febrile respiratory illness among US military basic trainees

Variable by FRI outcome

Total study population

Adenovirus

Influenza

Other

( n = 21,570)

( n = 13,725)

( n = 1,435)

( n = 6,410)

Continuous variablese

valuea

valuea

valuea

valuea

Age (years)

20.8 (3.8)

20.5 (3.7)

21.2 (3.7)

21.2 (4.2)

Symptom duration (days)

3.0 (1-90)

3.0 (1-90)

3.0 (1-52)

3.0 (1-84)

Temperature (°C)

38.2 (1.5)

38.4 (1.5)

38.4 (1.3)

38.2 (1.5)

Smoking history (pack-years)

1.0 (0-99)

1.0 (0-99)

1.0 (0-72)

0.5 (0-40)

Days since vaccinationb (Influenza)

31.0 (0-365)

33.0 (0-363)

10.0 (0-351)

29.0 (0-365)

Training week

4.7 (3.0)

5.0 (2.6)

3.2 (3.2)

4.7 (3.8)

Categorical variablese

n (%)

n (%)

n (%)

n (%)

Training season

    

Fall

5,088 (23.6)

3,423 (24.9)

227 (15.8)

1,438 (22.4)

Spring

4,675 (21.7)

3,144 (22.9)

78 (5.4)

1,453 (22.7)

Summer

6,574 (30.5)

4,501 (32.8)

403 (28.1)

1,670 (26.1)

Winter

5,233 (24.3)

2,657 (19.4)

727 (50.7)

1,849 (28.8)

Sex

    

Female

2,846 (13.2)

1,568 (11.4)

252 (17.6)

1,026 (16.0)

Male

18,724 (86.8)

12,157 (88.6)

1,183 (82.4)

5,384 (84.0)

Acute onset

    

≤3 days

12,750 (59.1)

7,623 (55.5)

1,060 (73.9)

4,067 (63.4)

>3 days

8,820 (40.9)

6,102 (44.5)

375 (26.1)

2,343 (36.6)

Fever

    

≥38.0°C

17,917 (83.0)

11,945 (87.0)

1,232 (85.9)

4,740 (73.9)

<38.0°C

3,653 (17.0)

1,780 (13.0)

203 (14.1)

1,670 (26.1)

First visit

    

Yes

14,659 (68.0)

8,867 (64.6)

1,065 (74.2)

4,727 (73.7)

No

6,911 (32.0)

4,858 (35.4)

370 (25.8)

1,683 (26.2)

Pneumoniac

    

Yes

2,882 (13.4)

1,624 (11.8)

107 (7.5)

1,151 (18.0)

No

18,688 (86.6)

12,101 (88.1)

1,328 (92.5)

5,259 (82.0)

Sore throat

    

Yes

19,174 (88.9)

12,771 (93.0)

1,168 (81.3)

5,235 (81.7)

No

2,396 (11.1)

954 (7.0)

267 (18.6)

1,175 (18.3)

Cough

    

Yes

19,249 (89.2)

12,559 (91.5)

1,410 (98.3)

5,280 (82.4)

No

2,321 (10.7)

1,166 (8.5)

25 (1.7)

1,130 (17.6)

Shortness of breath

    

Yes

8,045 (37.3)

5,010 (36.5)

545 (38.0)

2,490 (38.8)

No

13,525 (62.7)

8,715 (63.5)

890 (62.0)

3,920 (61.2)

Nasal congestion

    

Yes

17242 (80.0)

11223 (81.8)

1153 (80.3)

4,866 (75.9)

No

4328 (20.1)

2502 (18.2)

282 (19.7)

1,544 (24.1)

Headache

    

Yes

17,890 (82.9)

1,1571 (84.3)

1,204 (84.0)

5,115 (79.8)

No

3680 (17.1)

2154 (15.7)

231 (16.0)

1,295 (20.2)

Conjunctivitis

    

Yes

1,901 (8.8)

1,224 (8.9)

76 (5.3)

601 (9.4)

No

19,669 (91.2)

12,501 (91.1)

1,359 (94.7)

5,809 (90.6)

Body aches

    

Yes

15,318 (71.0)

9,804 (71.4)

1,073 (74.8)

4,441 (69.3)

No

6,252 (29.0)

3,921 (28.6)

362 (25.2)

1,969 (30.7)

Nausea/vomiting

    

Yes

10,757 (49.9)

7,135 (51.9)

701 (48.9)

2,921 (45.6)

No

10,813 (50.1)

6,590 (48.1)

734 (51.1)

3,489 (54.4)

Asthma

    

Yes

1,153 (5.3)

670 (4.9)

85 (5.9)

398 (6.2)

No

20,417 (94.7)

13,055 (95.1)

1,350 (94.1)

6,012 (93.8)

Smoker

    

Yes

6,942 (32.2)

4,360 (31.8)

406 (28.3)

2,176 (33.9)

No

14,628 (67.8)

9,365 (68.2)

1,029 (71.7)

4,234 (66.1)

Vaccinated (influenza)d

    

Yes

14,005 (65.0)

8,685 (63.3)

888 (61.9)

4,432 (69.1)

No

7,565 (35.0)

5,040 (36.7)

547 (38.1)

1,978 (30.9)

  1. aContinuous variable values reported as “mean (standard deviation)” if symmetric variable or “median (min–max range)” if non-symmetric.
  2. bMissing data due to seasonal vaccine schedule-Total population, n = 6,067; Adenovirus group, n = 3,670; Influenza group, n = 695; Other group, n = 1,702. Vaccination days were limited to vaccination within the last year.
  3. cAll pneumonias were provider diagnosed.
  4. dIndividuals were considered vaccinated if their vaccination date was ≥14 days.
  5. ep-value determination - χ2 was used for categorical variables; Kruskal Wallis test or one-way ANOVA for continuous variables. All variable were significant at P < .0001 except for shortness of breath (P =0.0300), body aches (P = 0.002), and asthma (P = 0.0002).